当前位置:首页 - 行情中心 - 开立医疗(300633) - 财务分析 - 现金流量表

开立医疗

(300633)

  

流通市值:122.72亿  总市值:122.72亿
流通股本:4.33亿   总股本:4.33亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金384,704,930.832,251,377,185.621,500,680,815.111,022,934,032.51
收到的税费返还44,508,830.86177,005,096.6133,759,453.2996,541,107.79
收到其他与经营活动有关的现金13,405,268.17117,630,323.5360,416,500.2453,337,793.84
经营活动现金流入的平衡项目0000
经营活动现金流入小计442,619,029.862,546,012,605.751,694,856,768.641,172,812,934.14
购买商品、接受劳务支付的现金268,968,554.45907,398,435.75582,552,650.58380,701,800.54
支付给职工以及为职工支付的现金296,451,100.56849,730,986.43651,268,066.41468,502,819.39
支付的各项税费45,251,378.93146,366,511.72127,807,075.5590,327,249.46
支付其他与经营活动有关的现金116,812,537.83335,858,416.47301,322,900.11218,167,951.33
经营活动现金流出的平衡项目0000
经营活动现金流出小计727,483,571.772,239,354,350.371,662,950,692.651,157,699,820.72
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-284,864,541.91306,658,255.3831,906,075.9915,113,113.42
二、投资活动产生的现金流量:
取得投资收益收到的现金4,535,533.274,800,056.752,784,607.331,772,315.1
处置固定资产、无形资产和其他长期资产收回的现金净额-194,388.27--
收到的其他与投资活动有关的现金495,000,0001,011,000,000779,000,000469,000,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计499,535,533.271,015,994,445.02781,784,607.33470,772,315.1
购建固定资产、无形资产和其他长期资产支付的现金39,512,245.19206,859,105.73185,802,545.25113,420,437.14
支付其他与投资活动有关的现金139,876,863.351,400,272,9001,023,887,500806,887,500
投资活动现金流出的平衡项目0000
投资活动现金流出小计179,389,108.541,607,132,005.731,209,690,045.25920,307,937.14
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额320,146,424.73-591,137,560.71-427,905,437.92-449,535,622.04
三、筹资活动产生的现金流量:
吸收投资收到的现金-31,398,906.931,398,906.931,398,906.9
取得借款收到的现金21,167,720.37412,071,846.6335,405,254.91335,405,254.91
筹资活动现金流入平衡项目0000
筹资活动现金流入小计21,167,720.37443,470,753.5366,804,161.81366,804,161.81
偿还债务支付的现金168,918,309.64133,638,320.07--
分配股利、利润或偿付利息支付的现金1,407,624.6144,335,404.11142,243,238.11140,201,757.17
支付其他与筹资活动有关的现金5,258,778.1183,259,920.6964,446,729.6636,282,081.66
筹资活动现金流出平衡项目0000
筹资活动现金流出小计175,584,712.35361,233,644.87206,689,967.77176,483,838.83
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-154,416,991.9882,237,108.63160,114,194.04190,320,322.98
四、汇率变动对现金及现金等价物的影响1,084,263.85-426,060.23-763,999.991,748,566.98
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-118,050,845.31-202,668,256.93-236,649,167.88-242,353,618.66
加:期初现金及现金等价物余额1,522,561,772.771,725,230,029.71,725,230,029.71,725,230,029.7
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,404,510,927.461,522,561,772.771,488,580,861.821,482,876,411.04
补充资料:
净利润-142,397,376.09-170,573,350.36
资产减值准备-118,144,693.87-25,467,960.83
固定资产和投资性房地产折旧-54,077,599.6-17,627,256.39
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-54,077,599.6-17,627,256.39
无形资产摊销-12,658,236.72-5,419,546.12
长期待摊费用摊销-5,795,242.42-3,204,007.79
处置固定资产、无形资产和其他长期资产的损失--49,467.49--
固定资产报废损失-1,110,734.24-814,360.24
公允价值变动损失--3,557,719.39--2,465,494.69
财务费用-7,390,290.82--261,479.87
投资损失--602,699.21-2,939,022.18
递延所得税--21,752,893.91--5,615,059.21
其中:递延所得税资产减少--21,752,893.91--5,586,651.25
递延所得税负债增加----28,407.96
存货的减少--294,870,527.05--148,451,443.14
经营性应收项目的减少--45,533,899.8--111,950,684.14
经营性应付项目的增加-318,331,765.8-28,619,510
其他--5,906,906.73-20,370,617.74
现金的期末余额-1,522,561,772.77-1,482,876,411.04
减:现金的期初余额-1,725,230,029.7-1,725,230,029.7
公告日期2025-04-262025-04-122024-10-262024-08-29
审计意见(境内)标准无保留意见
TOP↑